Matinas BioPharma (MTNB) announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as ...

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith ...

Corporate reorganizations are nothing new, but the targeted reorganization of HEOR groups comes at a time of significant change in the operational and competitive landscape for biopharma.

Featured here, the Income Statement (earnings report) for Matinas BioPharma Holdings Inc, showing the company's financial performance from operating and non operating activities such as revenue, ...

TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), today ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Benitec Biopharma Inc. (NASDAQ:BNTC), a clinical-stage biotechnology company with a market capitalization of $264 million, is making waves in the gene therapy space with its... ByInvesting.com • 17 ...

NEW YORK - Investment firm 111 Equity Group, LLC and its principal have increased their collective ownership stake in Matinas Biopharma Holdings, Inc. (NYSE American: MTNB) to... 111 Equity Group ...

Market Crashes For 5-Sessions In Row: Why Sensex Fell 817 Pts And Nifty Dipped 248 Pts On Monday, February 24? Stock Market Live Updates: Market In Bloodbath! Sensex, Nifty Down 1% Each; HCL Tech ...

The Food and Drug Administration on Friday gave a green light to a new meningococcal vaccine from GSK. Dubbed Penmenvy, the “5-in-1” shot is approved for people aged 10 through 25 years old and ...

Matinas BioPharma Holdings, Inc. - GlobeNewswire - Thu Feb 13, 4:00PM CST BEDMINSTER, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE ...

1 Day MTNB 1.55% DJIA -0.37% Russell 2K -0.10% Health Care/Life Sciences 0.69% ...